[The efficacy of intestinal dysbacteriosis correction in patients with bronchial asthma]

Altogether 119 patients with infectious-allergic bronchial asthma were examined for intestinal dysbacteriosis and for the immune status (T and B lymphocytes, TPS-RFC, TPR-RFC, IgA, IgM and IgG in blood and feces). Intestinal dysbacteriosis was discovered in 79.8 percent of the cases, more frequently in grave asthma course. Sixteen patients with grades II-III dysbacteriosis were treated with the bacterial preparations (colibacterin, bifidobacterin or bifikol) under outpatient conditions. As a result of the treatment the clinical signs of intestinal dysbacteriosis disappeared, the fecal microflora improved and the immune status returned to normal. However the blood concentration of IgG remained high.